Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab

Objective: To examine outcomes among patients who were treated with the targeted anti-cytokine agents, anakinra or tocilizumab, for COVID-19 -related cytokine storm (COVID19-CS). Methods: We conducted a retrospective cohort study of all SARS-coV2-RNA-positive patients treated with tocilizumab or ana...

Full description

Bibliographic Details
Main Authors: Annette Langer-Gould, Jessica B. Smith, Edlin G. Gonzales, Rhina D. Castillo, Judith Garza Figueroa, Anusha Ramanathan, Bonnie H. Li, Michael K. Gould
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
Cytokine storm
Anakinra
Tocilizumab
Corticosteroids
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220306093

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220306093

Similar Items